XML 44 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Mar. 24, 2013
Mar. 25, 2012
Cash flows from operating activities:    
Net income (loss) $ (82,742) $ 13,136
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 68,562 62,086
Amortization of acquisition-related intangible assets 5,023 6,651
Loss on disposal of fixed assets 4,333 1,674
Gain on disposition of property 0 (5,410)
Impairment of long-lived assets 2,791 0
Stock compensation expense 16,414 12,109
Gain on sale of investments (8) (44)
Other-than-temporary impairment of investments 350 2,383
Provision for bad debt (62) 957
Provision for inventory write downs 15,279 11,534
Loss (gain) on derivatives 165 (29)
Deferred income taxes 5,615 (8,837)
Tax benefit from stock-based awards 0 1,674
Excess tax benefit from stock-based awards 0 (830)
Changes in operating assets and liabilities, net 43,389 (119,323)
Other 2,522 5,007
Net cash provided by (used in) operating activities 81,631 (17,262)
Cash flow from investing activities:    
Additions to property, plant and equipment (60,924) (96,524)
Proceeds from sale of property, plant and equipment 118 5,524
Sale of investments 52,131 27,109
Maturities of investments 21,500 183,623
Purchase of investments (9,979) (160,260)
Release from restricted cash 174 690
Net cash provided by (used in) investing activities 3,020 (39,838)
Cash flows from financing activities:    
Proceeds from exercise of stock options 4,342 2,351
Excess tax benefit from stock-based awards 0 830
Purchase of treasury stock (5,210) (23,576)
Net settlement of restricted stock units for tax withholdings (1,492) (2,510)
Net cash used in financing activities (2,360) (22,905)
Effect of exchange rate changes on cash and cash equivalents (720) (1,226)
Net increase (decrease) in cash and cash equivalents 81,571 (81,231)
Cash and cash equivalents, beginning of period 305,423 298,731
Cash and cash equivalents, end of period $ 386,994 $ 217,500